- About CEED3
- Diabetes Information
- Diabetes Information
- Diabetes information - sites in Partner languages
- What is Monogenic Diabetes?
- Maturity-Onset Diabetes of the Young (MODY)
- Making a diagnosis of Monogenic Diabetes
- Monogenic Diabetes in Children - ISPAD Guidelines
- Neonatal Diabetes (Kir6.2)
- Renal Cysts and Diabetes (HNF1B)
- Other Types of Monogenic Diabetes
- Best Practice Guidelines
- Genetic Testing
- News & Events
- Research & Publications
- Links
- Contact Us
Work Packages
The CEED3 project aims to develop diagnostic tools which will allow clinicians to differentiate between subgroups of diabetes. This will allow more appropriate treatment for diabetic patients. The project work is divided into 6 work packages, and the management of CEED3.
Each work package has a lead institution, although all include the work of several partners in collaboration.
WP1 | Identification of putative biomarkers from human studies | ![]() |
University of Oxford |
WP2 | Identification of potential diagnostic biomarkers from model systems | ![]() |
Funacio Privada Clinic per la Recerca Biomedica |
WP3 | Validation & clinical application in the diagnosis of monogenic diabetes | ![]() |
University of Exeter |
WP4 | Validation & clinical application in the identification of subjects with initial beta-cell dysfunction | ![]() |
Lund University Hospital |
WP5 | Validation & clinical application in the identification of subjects with early development of vascular complications | ![]() |
Lund University Hospital |
WP6 | Dissemination, public engagement and physician training | ![]() |
Jagiellonian University Medical Colllege |
MGT | Management | ![]() |
University of Exeter |